Paraja, Asia M.

HRN: 04-67-26  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2023
CEFUROXIME 1.5GM (VIAL)
12/12/2023
12/18/2023
IV
1.5
Q8
Thickly Msaf
Waiting Final Action 
12/12/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/12/2023
12/18/2023
IV
500
Q8
Thickly Msaf
Waiting Final Action 
12/12/2023
CEFUROXIME 500MG (TAB)
12/12/2023
12/18/2023
PO
500 Mg
BID
TMSAF
Waiting Final Action 
12/12/2023
METRONIDAZOLE 500MG (TAB)
12/12/2023
12/18/2023
PO
500 Mg
TiD
TMSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: